Complete Hepatitis Profile at Dr. Essa Lab

Complete Hepatitis Profile at Dr. Essa Lab

Viral hepatitis remains a major global public health challenge, particularly in developing regions where infections often go undetected until they progress to chronic liver disease, cirrhosis, or hepatocellular carcinoma. The Complete Hepatitis Profile at Dr. Essa Lab is a comprehensive, multi-parameter serological panel designed to screen, diagnose, and differentiate infections caused by the primary hepatitis viruses, specifically Hepatitis A Virus (HAV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV). By evaluating a specific spectrum of viral antigens and host antibodies, this profile provides clinicians with a detailed map of a patient's immunological status, helping to distinguish between acute infections, chronic carrier states, past resolved infections, and vaccine-induced immunity.

The liver is a vital organ responsible for metabolic regulation, detoxification, protein synthesis, and bile production. When hepatitis viruses invade hepatic tissue, they trigger an inflammatory response that can lead to hepatocyte injury and necrosis. Because different hepatitis viruses share overlapping clinical presentations—such as fatigue, jaundice, abdominal pain, and elevated liver enzymes—serological testing is the only definitive method to identify the specific causative agent. Dr. Essa Lab utilizes state-of-the-art automated immunoassay platforms, including Chemiluminescent Microparticle Immunoassay (CMIA) and Enzyme-Linked Immunosorbent Assay (ELISA) technologies, to deliver highly sensitive and specific results. This diagnostic precision is essential for initiating timely therapeutic interventions, preventing transmission, and guiding long-term clinical management.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest accuracy of your Complete Hepatitis Profile at Dr. Essa Lab, patients are advised to follow these preparation guidelines:

• Fasting Requirements: Strict fasting is generally not required for a standard hepatitis serology panel. However, if your physician has ordered concurrent tests, such as a fasting blood sugar or lipid profile, you may need to fast for 8 to 12 hours.
• Medication Disclosure: Inform your healthcare provider and the laboratory staff about all prescription medications, over-the-counter drugs, vitamins, and herbal supplements you are currently taking, as certain immunosuppressive therapies can influence antibody production.
• Hydration: Drink plenty of water before the test. Being well-hydrated makes venipuncture easier by ensuring your veins are full and accessible.
• Avoid Alcohol: Refrain from consuming alcohol for at least 24 hours prior to the blood draw, as alcohol can stress the liver and temporarily alter baseline liver enzyme levels if concurrent liver function tests are performed.

During the Procedure

The Complete Hepatitis Profile is performed on a standard venous blood sample. The entire procedure is quick, safe, and conducted under strict aseptic conditions by experienced phlebotomists at Dr. Essa Lab:

• Patient Positioning: You will be seated comfortably in a blood collection chair, and you will be asked to extend your arm.
• Vein Selection: The phlebotomist will inspect your arm, typically the antecubital fossa (inner elbow), to locate a suitable, prominent vein.
• Sanitization: The skin over the selected vein is thoroughly cleansed with an antiseptic swab (usually 70% isopropyl alcohol) to prevent contamination.
• Tourniquet Application: A rubber tourniquet is tied around your upper arm to restrict blood flow temporarily, causing the veins to swell and become more visible.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube is gently inserted into the vein. You may feel a brief pinch or stinging sensation.
• Sample Collection: Blood is drawn into a gold-top or red-top serum separator tube (SST). Once the required volume is collected, the tourniquet is released.
• Post-Puncture Care: The needle is smoothly withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to stop bleeding. A small adhesive bandage is then applied.
• Duration: The entire blood collection process takes less than five minutes, and patients can immediately resume their normal daily activities.

When is a Complete Hepatitis Profile Performed?

Evaluation of Acute Jaundice and Liver Dysfunction

Physicians frequently request a Complete Hepatitis Profile when a patient presents with signs of acute hepatic inflammation, most notably jaundice (yellowing of the skin and sclera). Jaundice occurs when damaged hepatocytes are unable to process and excrete bilirubin, leading to its accumulation in bodily tissues. This presentation is often accompanied by dark-colored urine, pale stools, and right upper quadrant abdominal pain. By testing for acute markers like Hepatitis A IgM and Hepatitis B Core IgM, the profile helps clinicians rapidly determine if a viral infection is the primary driver of the acute liver injury.

Screening High-Risk Populations and Healthcare Workers

Screening is a cornerstone of preventive medicine, especially for individuals at elevated risk of contracting bloodborne pathogens. This includes healthcare professionals, laboratory personnel, individuals undergoing hemodialysis, intravenous drug users, and those with multiple sexual partners. The Complete Hepatitis Profile is routinely performed to assess baseline immunity, detect asymptomatic chronic infections (particularly Hepatitis B and C), and determine the necessity of vaccination or post-exposure prophylaxis in clinical and occupational settings.

Investigating Chronic Fatigue and Unexplained Symptoms

Chronic viral hepatitis, particularly Hepatitis C, is often referred to as a "silent killer" because it can remain asymptomatic for decades while progressively damaging the liver. Patients may only experience vague, non-specific symptoms such as persistent fatigue, mild joint pain, unexplained weight loss, or cognitive fog. When routine blood panels reveal persistently elevated liver transaminases (ALT and AST) without an obvious cause, a Complete Hepatitis Profile is indicated to rule out underlying chronic viral infections before irreversible liver scarring occurs.

Pre-Employment and Prenatal Medical Screening

Many organizations, academic institutions, and international visa authorities require a comprehensive health clearance that includes hepatitis screening. Furthermore, prenatal screening is universally recommended for pregnant women. Detecting Hepatitis B surface antigen (HBsAg) in expectant mothers is critical, as vertical transmission during childbirth can be prevented by administering the Hepatitis B vaccine and Hepatitis B Immune Globulin (HBIG) to the newborn within hours of birth, preventing chronic infection in the child.

Monitoring Chronic Viral Hepatitis Infections

For patients with known histories of viral hepatitis, this profile serves as an essential monitoring tool. It helps clinicians track the natural history of the disease, evaluate whether a patient has achieved seroconversion (switching from antigen-positive to antibody-positive status), assess the risk of reactivation in patients undergoing chemotherapy or immunosuppressive therapy, and determine the efficacy of antiviral treatment protocols.

What Does a Complete Hepatitis Profile Detect?

The Complete Hepatitis Profile at Dr. Essa Lab evaluates a comprehensive array of viral markers to provide a detailed diagnostic picture. The panel detects and differentiates the following clinical findings:

• Active Acute Hepatitis A Infection: Indicated by the presence of Anti-HAV IgM antibodies, representing recent exposure and active acute infection.
• Past Exposure or Immunity to Hepatitis A: Indicated by Anti-HAV IgG (or Total Anti-HAV with negative IgM), showing immunity acquired through previous infection or vaccination.
• Active Hepatitis B Infection: Detected via the presence of Hepatitis B Surface Antigen (HBsAg), the primary screening marker for active HBV.
• Chronic Hepatitis B Carrier State: Indicated by the persistence of HBsAg in the blood for more than six months.
• Acute Hepatitis B Infection (Early Phase): Characterized by high levels of HBsAg and positive Anti-HBc IgM antibodies.
• Immunity to Hepatitis B via Vaccination: Indicated by the isolated presence of Anti-HBs (Hepatitis B Surface Antibody) with all other markers negative.
• Immunity to Hepatitis B via Natural Infection: Indicated by the presence of both Anti-HBs and Anti-HBc Total antibodies, with negative HBsAg.
• Occult or Resolved Hepatitis B Infection: Suggested by the presence of Anti-HBc Total antibodies in the absence of HBsAg and Anti-HBs.
• Active Hepatitis C Infection: Initially screened via the presence of Anti-HCV antibodies, which indicates exposure to the virus.
• Acute Hepatitis C Phase: Often presents with fluctuating liver enzymes and positive Anti-HCV, requiring confirmatory molecular testing.
• Resolved Hepatitis C Infection: Indicated when a patient has positive Anti-HCV antibodies but undetectable HCV RNA on subsequent molecular testing.
• Chronic Hepatitis C Infection: Confirmed when Anti-HCV antibodies are present alongside detectable viral replication via PCR.
• Co-infection with Multiple Hepatitis Viruses: The profile can detect simultaneous infections, such as concurrent HBV and HCV, which significantly increases the risk of rapid liver disease progression.
• Early Window Period of HBV: Identified when HBsAg is positive but antibodies have not yet developed.
• Early Window Period of HCV: A state where a patient may be infected but has not yet mounted a detectable antibody response, requiring clinical correlation.
• Vaccine Failure or Non-Responder Status: Indicated by the absence of Anti-HBs antibodies following a complete Hepatitis B vaccination series.
• Reactivation of Latent Hepatitis B: Indicated by the reappearance of HBsAg or a rise in viral markers in a patient who previously had resolved or inactive infection.
• Acute Hepatic Necrosis Risk: Correlated when positive acute viral markers align with extremely elevated liver transaminases.
• Asymptomatic Viral Shedding: Identification of infectious individuals who do not exhibit clinical symptoms but can transmit the virus.
• Need for Confirmatory Molecular Testing: Highlighting cases where serological patterns require quantitative PCR testing for definitive treatment planning.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is committed to delivering prompt and highly reliable diagnostic reports. The standard turnaround time for the Complete Hepatitis Profile is typically within 24 to 48 hours from the time of sample collection. Because viral serology requires meticulous processing and quality control checks to eliminate false positives or negatives, our clinical pathologists review every batch of results carefully.

Once your report is finalized, Dr. Essa Lab offers multiple convenient ways to access your results. Patients receive an automated SMS notification containing a direct link to download their electronic report (e-report) in PDF format. Reports can also be accessed securely through the official Dr. Essa Lab website by entering the patient lab ID and password provided on the receipt. For those who prefer physical copies, printed reports can be collected from any of our convenient diagnostic centers or home-delivered via our dedicated courier service.

Complete Hepatitis Profile Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hepatitis A IgM (Anti-HAV IgM)	Negative (Non-reactive)	Positive (Reactive) – Indicates acute or very recent Hepatitis A infection.
Hepatitis A Total/IgG (Anti-HAV)	Negative (Non-reactive)	Positive (Reactive) – Indicates immunity due to past natural infection or vaccination.
Hepatitis B Surface Antigen (HBsAg)	Negative (Non-reactive)	Positive (Reactive) – Indicates active (acute or chronic) Hepatitis B infection.
Hepatitis B Surface Antibody (Anti-HBs)	Negative (< 10 mIU/mL)	Positive (≥ 10 mIU/mL) – Indicates immunity to Hepatitis B from vaccination or resolved infection.
Hepatitis B Core Antibody IgM (Anti-HBc IgM)	Negative (Non-reactive)	Positive (Reactive) – Indicates acute or recent Hepatitis B infection (within 6 months).
Hepatitis B Core Antibody Total (Anti-HBc Total)	Negative (Non-reactive)	Positive (Reactive) – Indicates past resolved or ongoing chronic Hepatitis B infection.
Hepatitis C Antibody (Anti-HCV)	Negative (Non-reactive)	Positive (Reactive) – Indicates exposure to Hepatitis C; requires confirmatory HCV RNA PCR.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Complete Hepatitis Profile?

• Experienced Healthcare Professionals: Our team consists of highly qualified clinical pathologists, microbiologists, and skilled phlebotomists dedicated to maintaining the highest clinical standards.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality at every stage of the diagnostic journey.
• Quality Diagnostic Services: Dr. Essa Lab utilizes advanced, fully automated immunoassay platforms to ensure exceptional precision and minimize human error.
• Professional Reporting: Our reports are structured clearly, providing comprehensive reference ranges and immunological interpretations to assist your physician.
• Modern Diagnostic Approach: We continuously upgrade our laboratory infrastructure to incorporate the latest international diagnostic protocols and quality control measures.
• Comfortable Environment: Our diagnostic centers are designed to offer a clean, hygienic, and welcoming atmosphere for all patients.
• Convenient Location: With an extensive network of branches across Karachi and other major cities, accessing our diagnostic services is easy and convenient.
• Commitment to Accurate Diagnosis: Established in 1987, Dr. Essa Lab has built decades of trust through unwavering dedication to diagnostic accuracy and community health.